| We are pleased to invite you to a virtual analyst and investor event on Tuesday, 26 July 2022, to discuss Roche’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Chicago, Illinois (July 24-28, 2022). Please note that since the overwhelming majority of registrations was for a virtual participation, it has been decided to switch the event to a virtual format only (no on site event). 6:00 - 7:15 pm CDT / 7:00 - 8:15 pm EDT / 4:00 - 5:15 pm PDT AACC brings together the global leaders in clinical chemistry, molecular diagnostics and lab management, and is the largest dedicated exhibition of equipment, instruments and services for clinical laboratories in the world. The webinar will start with a presentation on the Diagnostics Division and on AACC highlights followed by a Q&A session (live access to the speakers). The presentation slides will be available for download from the IR website at 5:00pm CDT on the day of the event. > click here. Presenters:
Access to virtual event (pre-registration required) Please pre-register for our webinar here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the live webinar will be available via > ir.roche.com *privacy notice Best regards, | |||
| Bruno Eschli Head of Investor Relations | Birgit Masjost Investor Relations Officer | ||
| Roche Investor Relations | |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.